MedTech Rising is one of Ireland’s leading annual gatherings for medtech companies, investors, clinicians, researchers and industry partners. Hosted by the Irish Medtech Association (Ibec), Enterprise Ireland, and IDA Ireland, the conference brings together sector leaders to discuss global medtech trends, innovation, regulation, digital health, manufacturing, talent, and the evolving challenges facing the industry.
ReaDI-Watch attended MedTech Rising 2025 to engage with delegates and hear perspectives from across the ecosystem. The event offered strong opportunities to understand how organisations are approaching R&D, clinical validation, AI adoption, sustainability, leadership development and innovation more broadly. This year’s programme included contributions from senior figures across Aerogen, EY, Ibec, Alcon Ireland, Dexcom, Atlantic Bridge, Teleflex, Stragilon, HealthBeacon, Trinzo, Integer, Stryker, Boston Scientific, Enterprise Ireland, IDA Ireland, BioInnovate, ProVerum, SymPhysis Medical, Amara Therapeutics and others.
Key insights from the day included:
Sector signals:
Global medtech continues to adapt to economic uncertainty, regulatory complexity, supply chain shifts and rapid technological change. Companies highlighted the importance of stronger evidence generation, secure and responsible use of AI, cost-effective manufacturing and building organisational resilience.
Innovation and R&D trends:
Speakers emphasised earlier engagement with clinicians, clearer documentation of R&D activity, the rising importance of digital and AI-enabled solutions and the need for robust data governance.
Opportunities for ReaDI-Watch:
The themes of the conference aligned closely with ReaDI-Watch’s support for R&D documentation, funding readiness, innovation strategy mapping and strengthening organisational capability. Engagement with speakers and delegates will support ongoing outreach to companies preparing for grants, tax incentives and R&D reporting requirements.